European Commission Approves DARZALEX as First Licensed Treatment for High-Risk Smouldering Multiple Myeloma Read more
Gefurulimab Shows Significant Improvement in Daily Function for gMG Patients in Phase III PREVAIL Trial Read more
AusperBio Secures China CDE Clearance to Launch Phase III Trial for AHB-137 in Chronic Hepatitis B Read more